Eye point pharma
Feb 17, 2020
Promising therapies that might shift Wet Age-related Macular Degeneration Market in the next decade
With no effective cure in Wet Age-related macular degeneration (Wet AMD) treatment market, the need of new therapies that can not only slow down the progression of the vision loss but also kill the cause behind the degeneration of the macula. The present treatment approach requires intravitreal injection of anti-VE...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
